XML 75 R46.htm IDEA: XBRL DOCUMENT v3.22.4
GOODWILL AND INTANGIBLE ASSETS (Tables)
 12 Months Ended
Dec. 31, 2022
Goodwill and Intangible Assets Disclosure [Abstract]  
Schedule of Reconciliation of Changes in the Company's Goodwill
A reconciliation of changes in the Company’s goodwill by reportable segment were as follows:
(in millions)Technologies & EquipmentConsumablesTotal
Balance at December 31, 2020
Goodwill$5,985 $894 $6,879 
Accumulated impairment losses(2,893)— (2,893)
Goodwill, net$3,092 $894 $3,986 
Acquisition related additions (a)
109 — 109
Translation and other(105)(14)(119)
Balance at December 31, 2021
Goodwill$5,989 $880 $6,869 
Accumulated impairment losses(2,893)— (2,893)
Goodwill, net$3,096 $880 $3,976 
Impairment(1,187)— (1,187)
Translation and other(87)(14)(101)
Balance at December 31, 2022
Goodwill$5,902 $866 $6,768 
Accumulated impairment losses(4,080)— (4,080)
Goodwill, net$1,822 $866 $2,688 
(a) Refer to Note 6, Business Combinations, for more information regarding recent acquisitions.
Schedule of Identifiable Definite-Lived Intangible Assets
Identifiable definite-lived and indefinite-lived intangible assets at were as follows:
Year Ended December 31,
 20222021
(in millions) 
Gross
Carrying
Amount
Accumulated
Amortization
Net
Carrying
Amount
Gross
Carrying
Amount
Accumulated
Amortization
Net
Carrying
Amount
Developed technology and patents$1,658 $(848)$810 $1,729 $(762)$967 
Tradenames and trademarks273 (96)177 269 (79)190 
Licensing agreements30 (26)4 36 (32)4 
Customer relationships1,057 (600)457 1,091 (545)546 
Total definite-lived$3,018 $(1,570)$1,448 $3,125 $(1,418)$1,707 
Indefinite-lived tradenames and trademarks450 — 450 598 — 598 
In-process R&D (a)
5 — 5 14 — 14 
Total indefinite-lived455 — 455 612 — 612 
Total identifiable intangible assets$3,473 $(1,570)$1,903 $3,737 $(1,418)$2,319 
(a) Intangible assets acquired in a business combination that are in-process and used in R&D activities are considered indefinite-lived until the completion or abandonment of the R&D efforts. The useful life and amortization of those assets will be determined once the R&D efforts are completed. During the third quarter of 2022, the completion of certain R&D activities occurred, resulting in the reclassification of $5 million of in-process R&D to in-service assets with a definite life. In the fourth quarter of 2022, the Company made the determination to abandon certain in-process R&D efforts, and recorded a $3 million impairment charge of in-process R&D assets.
Schedule of Indefinite-Lived Intangible Assets
Identifiable definite-lived and indefinite-lived intangible assets at were as follows:
Year Ended December 31,
 20222021
(in millions) 
Gross
Carrying
Amount
Accumulated
Amortization
Net
Carrying
Amount
Gross
Carrying
Amount
Accumulated
Amortization
Net
Carrying
Amount
Developed technology and patents$1,658 $(848)$810 $1,729 $(762)$967 
Tradenames and trademarks273 (96)177 269 (79)190 
Licensing agreements30 (26)4 36 (32)4 
Customer relationships1,057 (600)457 1,091 (545)546 
Total definite-lived$3,018 $(1,570)$1,448 $3,125 $(1,418)$1,707 
Indefinite-lived tradenames and trademarks450 — 450 598 — 598 
In-process R&D (a)
5 — 5 14 — 14 
Total indefinite-lived455 — 455 612 — 612 
Total identifiable intangible assets$3,473 $(1,570)$1,903 $3,737 $(1,418)$2,319 
(a) Intangible assets acquired in a business combination that are in-process and used in R&D activities are considered indefinite-lived until the completion or abandonment of the R&D efforts. The useful life and amortization of those assets will be determined once the R&D efforts are completed. During the third quarter of 2022, the completion of certain R&D activities occurred, resulting in the reclassification of $5 million of in-process R&D to in-service assets with a definite life. In the fourth quarter of 2022, the Company made the determination to abandon certain in-process R&D efforts, and recorded a $3 million impairment charge of in-process R&D assets.